Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Biomarkers in Heart Failure with Preserved Ejection Fraction
Author(s): Antoni Bayés-Genís , Germán Cediel , Mar Domingo , et al Added: 1 year ago

Heart Failure
eSPACE Heart Failure 2022
Author(s): Stefan Anker , Andrew JS Coats , Shelley Zieroth Start date: Oct 14, 2022

Heart Failure
Heart Failure Online 2022
Author(s): Andrew JS Coats , Ileana L Piña , Shelley Zieroth Start date: May 04, 2022

Heart Failure
CRT 2019: 1 Year Outcomes From SURTAVI - Dr Steven Yakubov
Author(s): Steven Yakubov Added: 5 years ago
Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial. Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. Why did you conduct this analysis? 2. How was data collected and analysed? 3. What were your findings? 4. How… View more

Intervention
Supplementary Material Video 1: Isolated Left Ventricular Apical Hypoplasia
Author(s): Abhishek Dattani , Rachana Prasad Added: 2 years ago
Cardiac Failure Review 2021;7:e21.https://doi.org/10.15420/cfr.2021.24 View more

Imaging & Diagnostics

Heart Failure
Author(s): Ileana L Piña , Gianluigi Savarese , , et al Start date: Mar 22, 2024

Heart Failure

Prevention & Chronic Conditions
Heart Failure in Focus Podcast - Ep 1
Author(s): Muthiah Vaduganathan , Scott Solomon Added: 1 year ago
Until recently, guideline directed medical therapy for HFpEF and HFmrEF was aimed at symptom control with mostly diuretic-based treatments. The publication of EMPEROR-PRESERVED in 2021 prompted changes in the AHA/ACC/HFSA guidelines, assigning a 2a recommendation across the SGLT-2 inhibitor class for use in this patient population. Since then, the heart failure community has been waiting in… View more

Heart Failure
Ep 1: Breaking the Cycle of HFpEF and Atrial Fibrillation
Added: 1 year ago
In this episode of the Radcliffe Cardiology Podcast, Dr Otilia Tica (University of Medicine of Oradea, Oradea, RO) is joined by Patient Representative, Mary Stanbury to outline ways in which cardiologists can break the cycle of heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF). This discussion is centered around a recently published article authored by Dr Tica in… View more
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
Author(s): Veronika Zach , Felix Lucas Bähr , Frank Edelmann Added: 4 years ago
Heart failure (HF) is a chronic, progressive disease with steadily increasing incidence rates and high morbidity and mortality that represents a major challenge in healthcare worldwide.1–3 The disease is characterised by chronic exacerbations, recurrent hospitalisations and poor prognosis.1,2 Survival rates in HF patients are lower than in patients suffering from some malignant diseases,… View more

Heart Failure

Electrophysiology & Arrhythmia
Author(s): Amam Mbakwem , Francis Aina , Casmir Amadi Added: 3 years ago
The prevalence of major depression in chronic heart failure (HF) is about 20–40 %, which is 4–5 % higher than in the normal population.1–3 Depression in heart failure has become a major issue as the burden of heart failure has continued to increase, and many studies have suggested poorer outcomes in HF patients reporting depression.4–8 The cost of managing HF has continued to escalate, and high… View more

Heart Failure

Prevention & Chronic Conditions